Exencephaly is a very severe birth defect of early brain development. In exencephaly, the top bones of the skull (the cranial vault) do not form. Because the skull is missing, the developing brain is left uncovered and floats in the amniotic fluid. This exposed brain tissue soon breaks down. Over time, exencephaly usually progresses to anencephaly, where most of the brain and skull are absent. Doctors view exencephaly and anencephaly as steps in the same process, often called the acrania–exencephaly–anencephaly sequence (AEAS). Sadly, the condition is not compatible with long-term survival. PMC+1
Exencephaly is a severe neural tube defect (NTD) in which the fetal skull (calvarium) fails to form and the developing brain is exposed to amniotic fluid. As pregnancy progresses, the exposed brain tissue degenerates, and the condition typically evolves into anencephaly (absence of the major portions of the brain and skull). Exencephaly is therefore considered part of the acrania–exencephaly–anencephaly sequence (AEAS) and is uniformly fatal; there is no curative treatment. Diagnosis is usually made on first-trimester ultrasound. Fetal Medicine Foundation+1
The brain and spinal cord begin as a flat sheet that rolls up into a tube; this “neural tube” normally closes by about 26–28 days after fertilization (4–6 weeks after the last menstrual period). If the cranial (head) end does not close or the skull fails to form, the brain remains unprotected and degenerates in the amniotic fluid, producing exencephaly and, later, anencephaly. Because this all happens so early—often before a person knows they are pregnant—primary prevention focuses on periconceptional folic acid. JAMA Network+1
Other names
People may hear several names that refer to the same spectrum of problems:
Exencephaly (the uncovered brain stage).
Acrania with exencephaly (when skull bones are absent and brain tissue is exposed).
Exencephaly–anencephaly sequence or acrania–exencephaly–anencephaly sequence (AEAS).
Open cranial neural tube defect (a broader category that includes exencephaly/anencephaly).
Craniorachischisis (a related, even more severe defect in which both the skull/brain and spine remain open). AJOG+2Fetal Medicine Foundation+2
Very early in pregnancy—about the 3rd to 4th week after conception—the top end of the neural tube (the embryo’s early brain and spinal cord) should close and then be covered by bone (the skull). In exencephaly, that closure and bony covering fail. The unprotected brain is bathed in amniotic fluid and gradually degenerates; this is why exencephaly often turns into anencephaly as pregnancy advances. ScienceDirect+1
Why does exencephaly happen?
Exencephaly is multifactorial: genes and environment both matter. Key, modifiable risks for all neural-tube defects include:
Low folate intake before and during very early pregnancy (weeks 3–4). Daily folic acid (see doses below) prevents many NTDs. CDC
Previous NTD-affected pregnancy raises recurrence risk; targeted high-dose folic acid is recommended when planning again. CDC
Pre-existing diabetes with poor early glycemic control increases major malformation risk; preconception optimization reduces risk. PMC+1
Maternal obesity (prepregnancy) approximately doubles NTD risk in meta-analyses. Weight optimization before conception helps. PubMed+1
Hyperthermia early in pregnancy (hot tubs/saunas or high fever) has been associated with more NTDs; avoid overheating. ACOG+1
Certain medicines (notably valproate) are strongly linked to NTDs; pregnancy-planning medication review with specialists is essential. Never stop meds without medical advice. JAMA Network
Possible vitamin B12 and choline insufficiency. Low B12 and inadequate choline intakes are associated with higher NTD risk in observational work; they do not replace folic acid. PMC+1
Types and presentations
Doctors don’t use rigid “types,” but you may see exencephaly described in these practical ways:
Primary exencephaly (developmental AEAS) – due to failure of the cranial neural tube to close and of skull bones to form; this is the classic pathway that typically evolves into anencephaly. ScienceDirect
Exencephaly from amniotic band sequence (disruptive) – rare cases where fibrous amniotic “bands” physically injure the forming head and leave brain tissue exposed. PMC+1
Exencephaly with craniorachischisis – the cranial defect occurs together with an open spine; this is the most severe open neural tube defect and is universally lethal. PMC+1
Early (first-trimester) exencephaly – recognized on ultrasound by the “Mickey-Mouse sign” (bulging brain tissue above an absent skull). Later, the brain tissue breaks down and classic anencephaly appears. PMC+1
Causes and risk factors
Exencephaly is multifactorial. Often, several risks add up. Not everyone with a risk factor will have an affected pregnancy.
Failure of closure of the top (rostral) neural tube – the basic biological cause behind AEAS. ScienceDirect
Low folic acid around conception – folic acid before and during very early pregnancy strongly lowers the risk of neural tube defects (NTDs). Public-health bodies recommend 400–800 µg daily for those who could become pregnant. JAMA Network+1
Maternal diabetes (pre-existing) – diabetes in early pregnancy raises the risk of NTDs, likely through effects on embryo development. Good preconception control reduces risk. PMC
Maternal obesity – higher body mass index is linked with higher NTD risk. PubMed+1
High fever or overheating (hyperthermia) in very early pregnancy – associated with increased NTD risk; avoid hot tubs/saunas in the first weeks. Lippincott Journals+1
Valproic acid (an anti-seizure drug) – a known human teratogen that increases major malformations, especially NTDs. Alternatives are considered when possible. Never change medication without specialist advice. New England Journal of Medicine+1
Carbamazepine (anti-seizure drug) – increases NTD risk (about 1% for spina bifida); folic acid is advised with preconception counseling. New England Journal of Medicine+1
Folate-antagonist medicines (e.g., methotrexate) – interfere with folate pathways and are associated with birth defects; they are avoided in pregnancy. PMC+1
Very high-glycemic diets/poor glucose control – may contribute to neural tube maldevelopment and add to diabetes risk. Oxford Academic
Amniotic band sequence – physical disruption from amniotic bands can produce exencephaly or similar cranial defects. PMC
Environmental toxic metals (e.g., arsenic, cadmium, lead) – growing human evidence suggests increased NTD risk with prenatal exposure. PMC
Certain pesticide exposures – some studies link agricultural pesticide exposure to higher NTD rates. Oxford Academic
Family history of NTDs / genetic susceptibility – NTDs cluster in families; multiple genes and gene–environment interactions are thought to play a role. MDPI
Insufficient folic-acid food fortification or supplement use – population programs that raise folate intake reduce NTDs; lack of access or use raises risk. JAMA Network
Fever-causing infections in very early pregnancy – fever itself (hyperthermia) is the suspected risk, not a specific germ. Pediatrics Publications
Chromosomal problems (rare with lethal open NTDs) – anencephaly/exencephaly are only rarely associated with trisomies like 18; most open cranial NTDs are not chromosomal. Obstetrics & Gynecology
Nutritional deficiencies beyond folate – overall poor nutrition may compound risk, often alongside folate insufficiency. (Public-health guidance still centers on folic acid.) JAMA Network
Folate-metabolism issues – variations in folate/one-carbon metabolism pathways may increase susceptibility when folate intake is low. MDPI
Multiple combined risks – for many families, several modest risks (e.g., low folate + fever + obesity) act together. MDPI
Infections that damage the early brain (e.g., Zika) – these cause serious brain malformations; a direct link to exencephaly is not established, but biologic plausibility is discussed. CDC+1
Symptoms and clinical features
A fetus cannot report “symptoms,” so clinicians describe features seen on scans, in lab screens, and at birth.
Missing skull bones (cranial vault) with exposed brain tissue—the hallmark appearance. Radiopaedia
Bulging or lobulated brain tissue above the face, especially on early scans (“Mickey-Mouse sign”). PMC
Progressive loss of brain tissue over time, so early images look different from later ones (transition to anencephaly). PMC
Very abnormal head shape, often irregular or “overhanging” due to lack of bone support. Journal of Ultrasonography
Prominent or protruding eyes (exophthalmos) in some cases because facial bones are affected by missing skull. Radiopaedia
Short or poorly defined neck when the defect is very extensive. PMC
Possible open spinal defect as well (craniorachischisis)—the brain and spine are both uncovered. CDC Archive
Polyhydramnios (too much amniotic fluid) later in pregnancy, because fetuses with severe brain defects often cannot swallow normally. (Common in open NTDs broadly.) AJOG
Elevated maternal serum alpha-fetoprotein (MSAFP) in the second trimester screening for open NTDs. PMC
Elevated amniotic fluid AFP and positive acetylcholinesterase (AChE) when amniocentesis is performed after a positive screen. FDA Access Data+1
Very poor survival after birth, when liveborn; survival beyond days is exceptional. ScienceDirect
Low Apgar scores and respiratory failure at delivery, reflecting severe brain damage (clinical course rather than a diagnostic sign). AJOG
Associated limb or facial anomalies if amniotic bands are present. PMC
Normal placenta or non-specific placental findings; a placental exam mainly helps rule out other causes or collect tissue for genetics. (General perinatal practice.)
Maternal grief and psychological distress—a vital, human aspect of this diagnosis that deserves compassionate care and support. (Clinical practice consensus.)
Diagnostic tests
A) Physical examination (after birth)
Immediate newborn inspection: The care team looks for absent skull bones and exposed brain tissue. This visual exam confirms the diagnosis at birth without special tools. Radiopaedia
Gentle palpation of the head and scalp area: Feeling the skull confirms that protective bones are absent and helps assess fragility of exposed tissue (handled with extreme care).
Head-circumference measurement: Often not meaningful in exencephaly because bone landmarks are missing, but it documents the anomaly.
Whole-body exam for other defects: Clinicians check the spine, limbs, and face for additional anomalies (e.g., craniorachischisis or amniotic-band injuries). CDC Archive+1
B) Manual/bedside clinical assessments
Fundal-height and Leopold maneuvers (during pregnancy): Hands-on abdominal checks that suggest unusual fetal head shape or size; not diagnostic alone but prompt urgent ultrasound.
Bedside cranial transillumination (postnatal): A bright light shone through tissues can highlight the absence of bone; it supports, but does not replace, imaging/inspection.
Photographic documentation with consent: Standard medical photos help multidisciplinary teams review findings and plan supportive care or autopsy examination.
(Note: Manual tests are adjuncts. Imaging and lab tests establish the diagnosis.)
C) Laboratory & pathological tests
Maternal serum alpha-fetoprotein (MSAFP): A second-trimester blood test. High levels suggest an open neural tube defect and trigger targeted ultrasound. PMC
Amniotic-fluid AFP (after amniocentesis): Confirms a truly elevated AFP in the amniotic fluid when the maternal blood test is high. FDA Access Data
Amniotic-fluid acetylcholinesterase (AChE): Often positive in open NTDs; it helps confirm that the fetus has an opening leaking neural tissue proteins. PMC
Genetic testing (karyotype or microarray) from chorionic villus sampling or amniocentesis: Not to “diagnose” exencephaly (which is structural), but to check for rare chromosomal abnormalities or other syndromes that may coexist. Obstetrics & Gynecology
Placental and fetal pathology (with parental consent): Tissue examination confirms the structural diagnosis and can document the AEAS stage for counseling. De Gruyter Brill
Maternal diabetes screening (A1c, glucose tests): Identifies an important modifiable risk that influences counseling for future pregnancies. PMC
D) Electrodiagnostic tests
Fetal heart-rate monitoring (non-stress test/CTG): May be used for general fetal well-being late in pregnancy but does not diagnose exencephaly.
Postnatal EEG (rarely relevant): In the extraordinary circumstance of a liveborn infant, EEG is sometimes attempted for documentation; it does not change the outcome.
(Note: Electrodiagnostic studies have little role in diagnosing exencephaly; they are listed here for completeness.)
E) Imaging tests
First-trimester ultrasound (often transvaginal): The most important early test. At 11–13 weeks, exencephaly shows absent skull with a characteristic “Mickey-Mouse” appearance of brain tissue above the face. PMC+1
Second-trimester targeted neurosonography: A detailed scan confirms the missing cranial vault, assesses brain tissue loss, and looks for spine or limb defects. Journal of Ultrasonography
3-D or high-resolution ultrasound: Helps parents and specialists understand anatomy and the AEAS stage more clearly. Journal of Ultrasonography
Fetal MRI (adjunct): Occasionally used to clarify anatomy or associated findings; ultrasound remains the main test. appliedradiology.com
Postnatal X-ray or CT (rarely needed): If a baby is liveborn, limited imaging can document the absence of skull bones; visual exam usually suffices. Radiopaedia
Treatments
There is no disease-modifying medical or surgical treatment for exencephaly. Management is ethical, supportive, and preventive: (a) accurate diagnosis, (b) informed counseling about options—including pregnancy termination where lawful or perinatal palliative comfort care if continuing—and (c) primary prevention for future pregnancies with folic acid. Any list of curative drugs, “immunity boosters,” regenerative or stem-cell therapies for exencephaly would be misleading and not evidence-based, so I will not invent such content. ACOG+1
Non-pharmacological supports
Below are real, evidence-informed non-drug supports used in practice. Each item says what it is, purpose, and how it helps. (Because exencephaly is lethal, these are about support, planning, and comfort, not cure.)
Perinatal palliative care program — A structured, multidisciplinary approach that centers comfort, reduces suffering, and honors family values from diagnosis through birth and after. Purpose: Align care with goals; provide continuity. Mechanism: Team-based planning (MFM, neonatology, palliative care, nursing, social work, chaplaincy). ACOG
Values-based decision counseling — Sensitive, non-directive counseling that lays out all legal options (termination, full intervention, or comfort care). Purpose: Informed consent. Mechanism: Clear explanation of prognosis and choices. ACOG
Personalized birth plan — A written plan for labor (e.g., monitoring choices) and newborn comfort steps (skin-to-skin, photos, memory-making). Purpose: Reduce uncertainty and distress. Mechanism: Anticipatory guidance. ACOG
Psychological support/therapy — Access to perinatal mental-health professionals for anticipatory grief, anxiety, and trauma processing. Purpose: Protect parental mental health. Mechanism: Evidence-based counseling and coping strategies. PMC
Social work support — Navigation of logistics (leave, finances, travel, childcare), links to community resources and bereavement groups. Purpose: Reduce practical burdens. Mechanism: Case management. ACOG
Spiritual/chaplaincy care — Respectful support for religious/cultural practices and rituals before/after birth. Purpose: Meaning-making and comfort. Mechanism: Integrates beliefs into the care plan. ACOG
Sibling and family preparation — Age-appropriate explanations and planning for family presence or viewing. Purpose: Reduce confusion and complicated grief. Mechanism: Child-life involvement and guidance. ACOG
Memory-making activities — Hand/footprints, photos, naming ceremonies. Purpose: Preserve connection and support grieving. Mechanism: Structured rituals integrated into birth plan. ACOG
Lactation counseling — Options after loss (suppression methods or donation). Purpose: Reduce physical discomfort; align with values. Mechanism: Evidence-based guidance. ACOG
Pain/comfort protocols for the newborn — Comfort-focused measures (warmth, swaddling, minimal handling). Purpose: Ease; dignity. Mechanism: Non-pharmacologic soothing first; meds only if needed. ScienceDirect
Care coordination across settings — Link clinic, hospital, and community hospice so plans match reality. Purpose: Consistency; fewer surprises. Mechanism: Shared documentation. PMC
Bereavement follow-up — Scheduled check-ins, support group referrals. Purpose: Reduce isolation; monitor for depression/PTSD. Mechanism: Structured outreach. perinatalhospice
Future pregnancy preconception counseling — Risk review and folic acid planning. Purpose: Prevention for next pregnancy. Mechanism: Start folic acid ≥1 month pre-conception. JAMA Network
Ethics consultation (as needed) — Helps when family/team values or goals differ. Purpose: Mediation and clarity. Mechanism: Formal ethics process. ACOG
Cultural liaison/translator services — Ensure understanding and respect for language/culture. Purpose: Equity and autonomy. Mechanism: Trained interpreters. ACOG
Informed monitoring choices — Many families elect no fetal monitoring to avoid cesarean for fetal indications when there’s no lasting neonatal benefit; others may choose monitoring to enable a live-birth ritual. Purpose: Align obstetric steps with goals. Mechanism: Shared decision-making. ACOG
Symptom plans for the birthing parent — Standard obstetric care (hydration, analgesia) tailored to the birth plan. Purpose: Safety and comfort. Mechanism: Anticipatory orders. ACOG
Community/online support networks — Peer support after prenatal loss or neonatal death. Purpose: Reduce loneliness; practical tips. Mechanism: Moderated groups and clinician-vetted resources. perinatalhospice
Documentation of keepsakes/permissions — Proactive consent for photos, mementos. Purpose: Avoid missed opportunities. Mechanism: Checklists. ACOG
Staff debriefing (indirect family benefit) — Team resilience reduces burnout and helps maintain compassionate care for families. Purpose: Sustain quality. Mechanism: Palliative care quality practices. PMC
Drug treatments
There are no disease-modifying drugs for exencephaly. Medications are used in two appropriate contexts:
A) Prevention for future pregnancies
Folic acid: For everyone who could become pregnant: 0.4 mg (400 mcg) daily, starting ≥1 month before conception and through the first trimester; continue prenatal vitamins during pregnancy (RDA during pregnancy is 600 mcg DFE). Purpose: Reduces NTD risk. How it works: Supports DNA synthesis and neural tube closure. Evidence: USPSTF/AMA-JAMA, NIH ODS, FDA nutrition guidance. JAMA Network+2Office of Dietary Supplements+2
High-risk folate dosing (prior NTD-affected pregnancy or certain high-risk situations): many guidelines advise 4–5 mg daily starting pre-conception through 12 weeks. Purpose/mechanism: As above, higher dose reduces recurrence risk. Evidence: ACOG PB 187 (4 mg), WHO recommends 5 mg for recurrence prevention. Lippincott Journals+1
Medication review (antiepileptics): Avoid valproate in pregnancy when alternatives exist; if anti-seizure therapy is essential, optimize regimen with neurology before conception. Purpose: Reduce NTD risk from teratogenic drugs. Evidence: FDA/AES position statements. U.S. Food and Drug Administration+1
B) Palliative comfort (newborn) — individualized by clinicians
Analgesics (e.g., opioids) for distress/pain if present; anxiolytics/sedatives if needed; antisecretory agents (e.g., glycopyrrolate) for secretions. Purpose: Comfort only, no life-prolonging intent. Mechanism: Symptom relief per neonatal palliative protocols; exact drugs/doses are tailored by specialists. Evidence: Perinatal palliative care guidance. ScienceDirect+1
(Note: Because correct dosing depends on gestational age, weight, and institutional protocols, dosing belongs in clinician orders rather than a general article.) ACOG
Dietary molecular supplements
Only folic acid is proven to prevent NTDs; vitamin B12 adequacy supports folate pathways. Others below are for overall pregnancy nutrition—not specific, proven NTD prevention.
Folic acid (synthetic folate) — 400 mcg/day for most; 4–5 mg/day for high-risk (per above). JAMA Network+1
Prenatal multivitamin — Ensures folate and other essentials (e.g., iron, iodine). Office of Dietary Supplements
Vitamin B12 — Critical cofactor; ensure adequacy, especially for vegetarians/vegans. Office of Dietary Supplements
Folate-fortified grains — Reliable source of folic acid in many countries. Office of Dietary Supplements
Folate-rich foods (leafy greens, legumes, citrus) — Complement supplements. Office of Dietary Supplements
Iodine (within prenatal) — General neurodevelopment support (not NTD-specific). Office of Dietary Supplements
Iron (as clinically indicated) — Maternal health; not NTD-specific. Office of Dietary Supplements
Vitamin D (as needed) — Maternal bone/immune health; not NTD-specific. Office of Dietary Supplements
Choline (dietary, sometimes in prenatals) — General neuronal development; limited NTD-specific evidence. Office of Dietary Supplements
Myo-inositol (investigational) — Studied for recurrence prevention in small cohorts; not standard of care; consider only in research settings with specialist advice. PMC
Important safety note: Avoid high-dose vitamin A/retinoids (including isotretinoin) in pregnancy because of strong teratogenicity. NCBI+1
Immunity-booster / regenerative / stem-cell drugs
There are none for exencephaly. No immune, regenerative, or stem-cell medication can reverse absent skull formation or brain tissue loss. Promoting such claims is unsafe and not evidence-based. Families should be protected from misinformation and directed to accurate prevention and palliative resources. ACOG
Surgeries
There is no fetal or neonatal surgery that can create a skull or restore destroyed brain tissue in exencephaly. (Fetal repair exists for spina bifida—a different NTD—but not for exencephaly/anencephaly.) Appropriate care is compassionate obstetric management plus palliative support. Lippincott Journals
Prevention tips
Take folic acid daily (400 mcg for all who could become pregnant; 4–5 mg if you’ve had a prior NTD—per local guideline). Start ≥1 month before conception. JAMA Network+2Lippincott Journals+2
Use prenatal vitamins that meet the 600 mcg DFE folate RDA during pregnancy. Office of Dietary Supplements
Review medications before pregnancy; avoid valproate if alternatives exist. U.S. Food and Drug Administration+1
Eat folate-rich foods and fortified grains in addition to supplements. Office of Dietary Supplements
Address B12 adequacy, especially with vegetarian/vegan diets. Office of Dietary Supplements
Early prenatal care—book visits promptly to enable first-trimester ultrasound screening. PubMed
Preconception counseling after any NTD-affected pregnancy to plan higher-dose folate and early screening. Lippincott Journals
Avoid retinoids/high-dose vitamin A in pregnancy; check all acne/skin meds and supplements. NCBI
Shared decision-making if an NTD is detected: request referral to perinatal palliative care to explore values-aligned options. ACOG
Public-health note: Support folic acid fortification policies where available—they reduce population NTD rates. JAMA Network
When to see a doctor
Before pregnancy (ideally 1–3 months before): start folic acid; review meds like anti-seizure drugs with specialists. JAMA Network+1
As soon as pregnancy is suspected: continue folic acid/prenatal vitamins and arrange early ultrasound. Office of Dietary Supplements
After any abnormal screen/ultrasound: ask for MFM referral and counseling on options (including perinatal palliative care, and legal limits on termination in your country). ACOG
After pregnancy loss or neonatal death: schedule follow-up for bereavement support and preconception planning for the future. perinatalhospice
What to eat and what to avoid
Eat more of:
Fortified grains (bread, pasta, cereals) for reliable folic acid. Office of Dietary Supplements
Leafy greens & legumes (natural folate). Office of Dietary Supplements
Citrus & berries (folate + vitamin C). Office of Dietary Supplements
Eggs, dairy, fish or B12-fortified foods (B12; supplement if vegetarian/vegan). Office of Dietary Supplements
Prenatal multivitamin every day (covers gaps). Office of Dietary Supplements
Avoid/limit:
- High-dose vitamin A/retinoids and acne retinoid drugs (teratogenic). NCBI
- Unsupervised supplements promising “immunity” or “regeneration” in pregnancy—no evidence and potential harm. AMA Journal of Ethics
- Valproate exposure in pregnancy unless no alternative; plan with neurology before conception. U.S. Food and Drug Administration
- Inconsistent folic acid use—make it a daily habit. JAMA Network
- Skipping early prenatal visits—timely ultrasound matters. PubMed
FAQs
1) Is exencephaly the same as anencephaly?
Not exactly; exencephaly is an earlier stage in the acrania–exencephaly–anencephaly sequence that usually progresses to anencephaly as pregnancy advances. Fetal Medicine Foundation
2) Can exencephaly be cured or repaired?
No. There is no medical or surgical cure; care focuses on accurate diagnosis, options counseling, and comfort-focused planning. Lippincott Journals
3) When is it detected?
Often at the first-trimester scan (11–14 weeks) by characteristic skull/brain findings (e.g., the “Mickey Mouse” sign). Radiopaedia
4) What lab screens pick it up?
Open NTDs can cause elevated maternal serum AFP; definitive assessment is by ultrasound. cfDNA does not screen for NTDs. ACOG
5) What choices do parents have after diagnosis?
Depending on local laws: pregnancy termination or continuation with perinatal palliative comfort care. Counseling must be non-directive and values-respectful. ACOG
6) If the pregnancy continues, what does newborn care look like?
Comfort-focused: warmth, family time, memory-making; medications only if needed to relieve distress. ScienceDirect
7) Can diet alone prevent exencephaly?
Diet helps, but daily folic acid before conception and in early pregnancy is crucial. JAMA Network
8) How much folic acid do I need?
Most people who could become pregnant: 400 mcg daily; those with a prior NTD-affected pregnancy: 4–5 mg daily per guideline. Start ≥1 month before conception. JAMA Network+2Lippincott Journals+2
9) Does MTHFR testing change folic acid advice?
No. Major genetics/obstetrics bodies do not recommend routine MTHFR testing for this; folic acid advice is unchanged. Nature
10) Which seizure medicines increase NTD risk?
Valproate carries a higher NTD risk; alternatives should be considered pre-conception with neurology. U.S. Food and Drug Administration
11) Will an exencephaly diagnosis affect future pregnancies?
You’ll receive recurrence counseling and a plan for higher-dose folate and early imaging in the next pregnancy. Lippincott Journals
12) Are there warning symptoms in the pregnant person?
Usually not; detection is by ultrasound and screening tests, not by physical symptoms. ACOG
13) Is fetal MRI required?
Not usually. Ultrasound is typically diagnostic; MRI can help in complex cases. PMC
14) Is surgery ever offered to “try everything”?
No surgery can create a skull or brain tissue; offering futile procedures is not appropriate. Palliative care centers comfort and dignity. ACOG
15) Where can families find structured support?
Ask for a perinatal palliative care referral; many hospitals have programs, and professional societies endorse this model. ACOG
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: September 17, 2025.
